(Q42849043)

8 November 2017

Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus (English)

1 reference

8 November 2017

1 reference

1 reference

1 reference

1 reference

Yifei Zhang

1

1 reference

8 November 2017

Xi Lu

2

1 reference

8 November 2017

Jie Hong

3

1 reference

8 November 2017

Menglei Chao

4

1 reference

8 November 2017

Weiqiong Gu

5

1 reference

8 November 2017

Weiqing Wang

6

1 reference

8 November 2017

Guang Ning

7

1 reference

8 November 2017

23 October 2010

1 reference

8 November 2017

1 reference

8 November 2017

38

1 reference

8 November 2017

2

1 reference

8 November 2017

181-187

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-010-9369-6

8 November 2017

0 references

cites work

Nonalcoholic fatty liver disease: diagnosis and relation to metabolic syndrome and approach to treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Lycopus lucidus inhibits high glucose-induced vascular inflammation in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Liver enzymes compared with alcohol consumption in predicting the risk of type 2 diabetes: the Kansai Healthcare Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Liver enzymes and incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Glucose intolerance and serum aminotransferase activities in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Nonalcoholic fatty liver disease and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Serum gamma-glutamyl transpeptidase is a determinant of insulin resistance independently of adiposity in Pima Indian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Interaction Between Body Mass Index and Alcohol Intake in Relation to Blood Pressure in HAN and SHE Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9369-6

Metabolic syndrome, hyperinsulinemia, and cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20972737

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[The relationship between serum adiponectin level and serum alanine aminotransferase elevation in Korean male with nonalcoholic fatty liver disease].

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20972737

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12020-010-9369-6

1 reference

Dimensions Publication ID

8 November 2017

0 references

1 reference